· 个股论点

分析AAOI光子学护城河与SOTP估值,认为其上行空间值得执行风险。

涉及标的:

中文翻译

感觉 $AAOI(市值75亿美元)是目前上行空间最大的 AI 交易之一? 在光子学领域,许多机构错过了上游瓶颈环节 $AXTI,因此散户可以在其被定价前发现这些机会。 对于 $AAOI,有一条清晰的通往 470 亿美元+ 估值的路径: 经济护城河: > 激光晶圆厂、设计及组装 > 德克萨斯州的激光产能翻三倍 > 美国制造(部分组装在台湾,但将于 2027 年回流美国) 预测: > 2027 年第二季度每月营收 3.78 亿美元 > 指引毛利率 35-38% -> 第三季度毛利率 40% 需求: > 超大规模云服务商买断了 $AAOI / $LITE / $COHR 能生产的所有产能 如果他们实现 2027 年下半年的营收目标: 激光组件权重:20% × 18.9 倍($LITE 估值倍数)= 3.78 倍 组装组件权重:80% × 8.5 倍(中际旭创/新易盛估值倍数)= 6.80 倍 $AAOI 的混合分部加总(SOTP) 估值倍数 = 10.58 倍远期销售额 如果他们实现预测,你仍然会得到 476 亿美元的市值。 这还不包括像 $MU 对比 SK 海力士那样赋予公司的“美国制造”溢价。 以及他们通过内部优化光模块(transceiver)供应链所获得的任何利润率扩张。 鉴于目前市值仅为 75 亿美元,我认为市场不会等到 2027 年第二季度才开始将其定价。 $AAOI 的上行空间值得承担执行风险吗? 对我来说:是的,毫无疑问。

英文原文

Feels like $AAOI ($7.5B MC) is one of the highest upside AI trades right now? With photonics lot of institutions miss upstream bottlenecks $AXTI, so retail can spot them before they get priced in. With AAOI, there’s a clear path to a $47B+ valuation from: Economic moat: > laser fab, the design, and the assembly > tripling laser capacity in Texas > made in America (some assembly in Taiwan but reshoring that to US in 2027) Projections: > $378m revenue per month in q2 2027 > guided 35-38% gross margins -> q3 40% gross margins Demand: > Hyperscalers buying out any capacity $AAOI / $LITE / $COHR can make If they hit their 2027 H2 revenue target: Laser Component Weight: 20% × 18.9x ( $LITE est. multiple) = 3.78x · Assembly Component Weight: 80% × 8.5x (Innolight/Eoptolink Multiple) = 6.80x · $AAOI’s Blended SOTP Multiple = 10.58x Forward Sales You still get a $47.6B Market Cap if they deliver projections. This is not including any potential Made in America premiums that get assigned to companies like $MU vs. SK Hynix. And any margin expansion they get from optimizing the transceiver supply chain in-house. Given the marketcap is a small $7.5B now, I don’t think markets will wait for q2 2027 to start pricing it in. Is the $AAOI upside worth the execution risk? To me: Yes, Unequivocally.

在 X 上查看原推 ↗